drugset / Trial / NCT01843634

Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia

NCT01843634 ↗

Phase 0 Completed 10 enrolled Jazz Pharmaceuticals
NaSingle-groupOpen-labelTreatment

Summary

This is an open-label pilot study evaluating the safety and preliminary evidence of a therapeutic effect of ODSH (2-0, 3-0 desulfated heparin) in conjunction with standard induction and consolidation therapy for acute myeloid leukemia.

Timeline

Start
2013-08
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject 2-0, 3-0, Desulfated Heparin Unknown — —